The group's principle activity is to provide nucleic acid testing for blood screening. The group's products include PROCLEIX(R) that are used to test more than 25 million blood donations annually in countries around the world, preventing thousands of HIV-1, hepatitis and West Nile virus transfusion-transmitted infections. The group operates from United States.
